Wall Street learned this week that Bristol Myers is expanding its heart drug business with a whopping $13 billion purchase of MyoKardia. The company announced on Monday that it would buy the company for about $13 billion in cash to bolster its porfolio of heart disease treatments. Shares of MyoKardia jumped 57.8% to $220.31 on … Continue reading “Bristol Myers to Acquire MyoKardia for $13 Billion”
Tag: Bristol-Myers Squibb
Hot Stocks
Jim Cramer Says These Stocks Are Worth Looking At Due to Coronavirus Fears
Over 4,000 are infected and over 100 already dead as China's mysterious Coronavirus continues to…
January 28, 2020
Biotech & Pharma
Bristol-Myers Has Withdrew its Application for Combination Lung Cancer Treatment
Bristol-Myers Squibb Co had a surprising announcement on Thursday as it reported financial results. The…
January 24, 2019
Biotech & Pharma
Bristol-Myers Squibb Gets FDA Approval for its Liver Drug Opdivo
It was an exciting day for Bristol-Myers Squibb on Monday. The Food and Drug Administration…
September 25, 2017